---
title: "Novo Nordisk hits 1-month high as judge allows part of shareholder suit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294242374.md"
description: "Novo Nordisk (NVO) rose over 1% to $51.59, hitting a 1-month high amid a shareholder lawsuit."
datetime: "2026-07-29T18:10:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294242374.md)
  - [en](https://longbridge.com/en/news/294242374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294242374.md)
---

# Novo Nordisk hits 1-month high as judge allows part of shareholder suit

诺和诺德公司 (NVO.US) 盘中涨超 1%，现报 51.59 美元。

股价创下近 1 个月新高，当日最高触及 51.83 美元。消息面上，联邦法官批准了针对诺和诺德的股东诉讼部分请求，认定投资者有合理理由声称公司关于 CagriSema 药物耐受性和临床试验设计的陈述存在误导。诺和诺德回应称指控毫无根据，将积极辩护。诉讼背景是来自礼来的竞争加剧以及 CagriSema 减肥数据令人失望。

另一方面，有分析指出诺和诺德基于现金流和盈利指标显示被低估，贴现现金流模型估算内在价值为每股 96 美元，较现价有 47.2% 的折让。其市盈率 12.2 倍低于行业平均水平，近期欧盟批准 Wegovy 也支撑未来现金流。

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Signaturefd LLC Buys 22,148 Shares of Novo Nordisk A/S $NVO](https://longbridge.com/en/news/295918811.md)
- [Exchange Traded Concepts LLC Cuts Stock Holdings in Novo Nordisk A/S $NVO](https://longbridge.com/en/news/295900999.md)
- [Saratoga Research & Investment Management Sells 200,320 Shares of Novo Nordisk A/S $NVO](https://longbridge.com/en/news/295918630.md)
- [Novo Nordisk A/S - share repurchase programme | NVO Stock News](https://longbridge.com/en/news/295416078.md)
- [Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation  | NVO Stock News](https://longbridge.com/en/news/294505570.md)